Galvin Joins Fox Chase Cancer Center as Director of Technology Transfer
PHILADELPHIA (September 18, 2000) -- Frances M. Galvin of Glen Mills, Pa. joins Fox Chase Cancer Center as the director of technology transfer in the Department of Business Development, Planning and Regulatory Affairs. Galvin most recently was the director of technology development at MCP Hahnemann University also in Philadelphia.
Galvin received her BA in Human Biology from Brown University in 1991. After graduation, she spent five years as a research assistant at the Dana-Farber Cancer Institute in Boston. Her work as a bench scientist focused on cellular immunology.
In 1996, Galvin took a position with the Dana-Farber Cancer Institute as a licensing assistant, negotiating more than 150 agreements between the Institute and other academic, industrial and government institutions.
Galvin is currently working on her MBA in Finance from Temple University.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.